Global Tuberculosis Diagnostic Market Research Report 2023

Publisher Name :
Date: 20-Feb-2023
No. of pages: 89
Inquire Before Buying

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

Highlights

The global Tuberculosis Diagnostic market was valued at US$ 2737.2 million in 2022 and is anticipated to reach US$ 3373.5 million by 2029, witnessing a CAGR of 3.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.

APAC is the largest market, with a share over 54%, followed by Americas and Europe, b

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tuberculosis Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Diagnostic.

The Tuberculosis Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tuberculosis Diagnostic market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tuberculosis Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Thermo Fisher Scientific

- Hologic Corporation

- Abbott

- Becton Dickinson

- Roche

- bioMerieux

- Sanofi

- Cepheid

- Hain Lifescience

- QIAGEN

Segment by Type

- Radiographic Method

- Diagnostic Laboratory Methods

- Nucleic Acid Testing

- Phage Assay

- Detection of Latent Infection

- Cytokine Detection Assay

- Detection of Drug Resistance

Segment by Application

- Infants

- Adults

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tuberculosis Diagnostic companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Tuberculosis Diagnostic Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radiographic Method
1.2.3 Diagnostic Laboratory Methods
1.2.4 Nucleic Acid Testing
1.2.5 Phage Assay
1.2.6 Detection of Latent Infection
1.2.7 Cytokine Detection Assay
1.2.8 Detection of Drug Resistance
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infants
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Diagnostic Market Perspective (2018-2029)
2.2 Tuberculosis Diagnostic Growth Trends by Region
2.2.1 Global Tuberculosis Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tuberculosis Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Tuberculosis Diagnostic Forecasted Market Size by Region (2024-2029)
2.3 Tuberculosis Diagnostic Market Dynamics
2.3.1 Tuberculosis Diagnostic Industry Trends
2.3.2 Tuberculosis Diagnostic Market Drivers
2.3.3 Tuberculosis Diagnostic Market Challenges
2.3.4 Tuberculosis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Diagnostic Players by Revenue
3.1.1 Global Top Tuberculosis Diagnostic Players by Revenue (2018-2023)
3.1.2 Global Tuberculosis Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Diagnostic Revenue
3.4 Global Tuberculosis Diagnostic Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2022
3.5 Tuberculosis Diagnostic Key Players Head office and Area Served
3.6 Key Players Tuberculosis Diagnostic Product Solution and Service
3.7 Date of Enter into Tuberculosis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Diagnostic Breakdown Data by Type
4.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2024-2029)
5 Tuberculosis Diagnostic Breakdown Data by Application
5.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tuberculosis Diagnostic Market Size (2018-2029)
6.2 North America Tuberculosis Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Tuberculosis Diagnostic Market Size by Country (2018-2023)
6.4 North America Tuberculosis Diagnostic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostic Market Size (2018-2029)
7.2 Europe Tuberculosis Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Tuberculosis Diagnostic Market Size by Country (2018-2023)
7.4 Europe Tuberculosis Diagnostic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnostic Market Size (2018-2029)
8.2 Asia-Pacific Tuberculosis Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis Diagnostic Market Size (2018-2029)
9.2 Latin America Tuberculosis Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Tuberculosis Diagnostic Market Size by Country (2018-2023)
9.4 Latin America Tuberculosis Diagnostic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnostic Market Size (2018-2029)
10.2 Middle East & Africa Tuberculosis Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Introduction
11.1.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Hologic Corporation
11.2.1 Hologic Corporation Company Detail
11.2.2 Hologic Corporation Business Overview
11.2.3 Hologic Corporation Tuberculosis Diagnostic Introduction
11.2.4 Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.2.5 Hologic Corporation Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Tuberculosis Diagnostic Introduction
11.3.4 Abbott Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Detail
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Tuberculosis Diagnostic Introduction
11.4.4 Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.4.5 Becton Dickinson Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Tuberculosis Diagnostic Introduction
11.5.4 Roche Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.5.5 Roche Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Detail
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Tuberculosis Diagnostic Introduction
11.6.4 bioMerieux Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.6.5 bioMerieux Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Tuberculosis Diagnostic Introduction
11.7.4 Sanofi Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.7.5 Sanofi Recent Development
11.8 Cepheid
11.8.1 Cepheid Company Detail
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Tuberculosis Diagnostic Introduction
11.8.4 Cepheid Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.8.5 Cepheid Recent Development
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Detail
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis Diagnostic Introduction
11.9.4 Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.9.5 Hain Lifescience Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Tuberculosis Diagnostic Introduction
11.10.4 QIAGEN Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.10.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Tuberculosis Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Radiographic Method
Table 3. Key Players of Diagnostic Laboratory Methods
Table 4. Key Players of Nucleic Acid Testing
Table 5. Key Players of Phage Assay
Table 6. Key Players of Detection of Latent Infection
Table 7. Key Players of Cytokine Detection Assay
Table 8. Key Players of Detection of Drug Resistance
Table 9. Global Tuberculosis Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Tuberculosis Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Tuberculosis Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Tuberculosis Diagnostic Market Share by Region (2018-2023)
Table 13. Global Tuberculosis Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Tuberculosis Diagnostic Market Share by Region (2024-2029)
Table 15. Tuberculosis Diagnostic Market Trends
Table 16. Tuberculosis Diagnostic Market Drivers
Table 17. Tuberculosis Diagnostic Market Challenges
Table 18. Tuberculosis Diagnostic Market Restraints
Table 19. Global Tuberculosis Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Tuberculosis Diagnostic Market Share by Players (2018-2023)
Table 21. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2022)
Table 22. Ranking of Global Top Tuberculosis Diagnostic Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Tuberculosis Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Tuberculosis Diagnostic Product Solution and Service
Table 26. Date of Enter into Tuberculosis Diagnostic Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Tuberculosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Tuberculosis Diagnostic Revenue Market Share by Type (2018-2023)
Table 30. Global Tuberculosis Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Tuberculosis Diagnostic Revenue Market Share by Type (2024-2029)
Table 32. Global Tuberculosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Tuberculosis Diagnostic Revenue Market Share by Application (2018-2023)
Table 34. Global Tuberculosis Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Tuberculosis Diagnostic Revenue Market Share by Application (2024-2029)
Table 36. North America Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. Europe Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 42. Asia-Pacific Tuberculosis Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 43. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2024-2029) & (US$ Million)
Table 45. Latin America Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Latin America Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 48. Middle East & Africa Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Tuberculosis Diagnostic Product
Table 54. Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Hologic Corporation Company Detail
Table 57. Hologic Corporation Business Overview
Table 58. Hologic Corporation Tuberculosis Diagnostic Product
Table 59. Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 60. Hologic Corporation Recent Development
Table 61. Abbott Company Detail
Table 62. Abbott Business Overview
Table 63. Abbott Tuberculosis Diagnostic Product
Table 64. Abbott Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Becton Dickinson Company Detail
Table 67. Becton Dickinson Business Overview
Table 68. Becton Dickinson Tuberculosis Diagnostic Product
Table 69. Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 70. Becton Dickinson Recent Development
Table 71. Roche Company Detail
Table 72. Roche Business Overview
Table 73. Roche Tuberculosis Diagnostic Product
Table 74. Roche Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 75. Roche Recent Development
Table 76. bioMerieux Company Detail
Table 77. bioMerieux Business Overview
Table 78. bioMerieux Tuberculosis Diagnostic Product
Table 79. bioMerieux Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 80. bioMerieux Recent Development
Table 81. Sanofi Company Detail
Table 82. Sanofi Business Overview
Table 83. Sanofi Tuberculosis Diagnostic Product
Table 84. Sanofi Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Cepheid Company Detail
Table 87. Cepheid Business Overview
Table 88. Cepheid Tuberculosis Diagnostic Product
Table 89. Cepheid Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 90. Cepheid Recent Development
Table 91. Hain Lifescience Company Detail
Table 92. Hain Lifescience Business Overview
Table 93. Hain Lifescience Tuberculosis Diagnostic Product
Table 94. Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 95. Hain Lifescience Recent Development
Table 96. QIAGEN Company Detail
Table 97. QIAGEN Business Overview
Table 98. QIAGEN Tuberculosis Diagnostic Product
Table 99. QIAGEN Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 100. QIAGEN Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Diagnostic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Tuberculosis Diagnostic Market Share by Type: 2022 VS 2029
Figure 3. Radiographic Method Features
Figure 4. Diagnostic Laboratory Methods Features
Figure 5. Nucleic Acid Testing Features
Figure 6. Phage Assay Features
Figure 7. Detection of Latent Infection Features
Figure 8. Cytokine Detection Assay Features
Figure 9. Detection of Drug Resistance Features
Figure 10. Global Tuberculosis Diagnostic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Tuberculosis Diagnostic Market Share by Application: 2022 VS 2029
Figure 12. Infants Case Studies
Figure 13. Adults Case Studies
Figure 14. Tuberculosis Diagnostic Report Years Considered
Figure 15. Global Tuberculosis Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Tuberculosis Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Tuberculosis Diagnostic Market Share by Region: 2022 VS 2029
Figure 18. Global Tuberculosis Diagnostic Market Share by Players in 2022
Figure 19. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostic Revenue in 2022
Figure 21. North America Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Tuberculosis Diagnostic Market Share by Country (2018-2029)
Figure 23. United States Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Tuberculosis Diagnostic Market Share by Country (2018-2029)
Figure 27. Germany Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Tuberculosis Diagnostic Market Share by Region (2018-2029)
Figure 35. China Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Tuberculosis Diagnostic Market Share by Country (2018-2029)
Figure 43. Mexico Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Tuberculosis Diagnostic Market Share by Country (2018-2029)
Figure 47. Turkey Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 50. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 51. Abbott Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 52. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 53. Roche Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 54. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 55. Sanofi Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 56. Cepheid Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 57. Hain Lifescience Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 58. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
  • Global Influenza Diagnostics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Influenza is an infectious disease and affects The upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to The influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are The essential first step for laboratory detection of influenz......
  • Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable gr......
  • Global POC Diagnostics Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global POC Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the POC Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period. The research report highlights the growth potential of the global POC Diagnostics market. POC Diagnostics are expected to show stable growth in the future market. However, product differentiatio......
  • Global Allergy Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Allergy Diagnostics market size was valued at US$ 5070.7 million in 2023. With growing demand in downstream market, the Allergy Diagnostics is forecast to a readjusted size of US$ 10550 million by 2030 with a CAGR of 11.0% during review period. The research report highlights the growth potential of the global Allergy Diagnostics market. Allergy Diagnostics are expected to show stable growth in the future market. However, prod......
  • Global Influenza Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Influenza Diagnostics market size was valued at US$ 2284.7 million in 2023. With growing demand in downstream market, the Influenza Diagnostics is forecast to a readjusted size of US$ 3558.7 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Influenza Diagnostics market. Influenza Diagnostics are expected to show stable growth in the future market. Howev......
  • Global Tuberculosis (TB) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2023 and is forecast to a readjusted size of USD 3635.2 million by 2030 with a CAGR of 4.3% during review period. Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, i......
  • Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2023 and is forecast to a readjusted size of USD 3620.3 million by 2030 with a CAGR of 6.0% during review period. Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus......
  • Global Point-of-Care Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Point-of-Care Diagnostics market: According to our latest research, the global Point-of-Care Diagnostics market looks promising in the next 5 years. As of 2022, the global Point-of-Care Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Viral Disease Diagnosis Professional Survey Report 2023, Forecast to 2028
    Published: 27-Nov-2023        Price: US 3280 Onwards        Pages: 105
    They have been used as an alternative method of diagnosing viral diseases. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared acr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs